Introduction
Autacoids, such as beta adrenergic catecholamines and histamine, are mediators and modulators of complex in vivo and in vitro models of inflammation and have lately become known as moderators of immunity (1) (2) (3) (4) (5) . These substances are made during different phases of response to antigen and are able, directly and indirectly, to affect further responses to antigen. It is possible that the concentration of autacoids in tissue during inflammation and immune response is sufficient to allow them to modify the functions of a number of cells that control and express both humoral and cell-mediated immunity. Histamine and beta adrenergic catecholamines modulate the activity of immunocompetent cells via specific receptors on the cell surface, but their precise distribution on subsets of T cells and the effect that different stages of development of the immune response have on them has not been determined. After binding to specific receptors on the lymphocytes, beta adrenergic agonists and histamine activate membrane adenylate cyclase and initiate the accumulation of intracellular adenosine 3',5' monophosphate (cyclic AMP). Considerable work has described immune modulatory effects caused by cAMP (6-8), but we do not know whether all of the effects of autacoids that modulate immunity work only through this second messenger or if there are alternative or additional mechanisms of action.
This report demonstrates the distinct effects of autacoids on phenotypically and functionally distinct subsets of human T cells. We demonstrate that autacoid receptors are distributed nonrandomly on subsets of T cells and that mitogens selectively affect subsets of T cells by stimulating the cells response to the ligands, presumably via effects on receptor availability. Expres- 
Methods
Isolation of subsets of lymphocytes from human peripheral blood. Mononuclear cells from peripheral blood of healthy volunteers were obtained by ficoll-hypaque gradient centrifugation of fresh defibrinated blood. T cells and non-T cells were isolated by a single step rosetting method using aminoethyesothiouroniumbromide hydrobromide (Sigma Chemical Co., St. Louis, MO)-treated sheep erythrocytes (SRBC). Rosette-forming T cells were separated on a second ficoll-hypaque gradient and freed from the SRBC by hypotonic lysis. The T cell fraction contained >95% E-rosette forming cells. The non-T cell fraction included 40-50% surface Ig-positive B cells, 30-50% alpha naphthyl acetate esterase-positive plastic adherent monocytes, and 5-10% nonadherent, nonsurface Ig-negative non-T and non-B cells.
Purified subsets of T cells were obtained by a panning technique which permitted the fractionation of fresh T cells into Leu 3+ and Leu 3-(2+) subpopulations. Indirect immunofluorescence and cell sorter analysis of Leu 3 panned cells showed that <2% of the unbound cells and >95% of the bound cells were Leu 3+. Similar subset purity was achieved when anti-Leu 2 was used as the panning antibody. The Leu 2+ (3-) population was further separated into 9.3+ and 9.3-subsets by panning with the 9.3 antibody. Cytofluorographic analysis of the 9.3-subpopulation of Leu 2+ cells showed that <3% of the unbound cells were 9.3+ compared with >95% of the bound cells (9) (10) (11) (12) .
Response to agonists after stimulation of subsets of T cells with phytohemagglutinin (PHA). Subsets of T cells were suspended to I X 10'/ml in RPMI 1640, 25 mM Hepes, 2 mM L-glutamine, 100 ug/ml streptomycin, 100 U/ml penicillin (all from Gibco Laboratories, Grand Island, NY), and 10% heat inactivated pooled human serum.
The cells were incubated with I yg/ml PHA (10-' M) , and intracellular accumulation of cAMP was measured as described.
Response to histamine, isoproterenol, and forskolin after Con A stimulation in subsets of T cells. After 24, 48, and 96 h of stimulation with Con A (25 ug/ml) and monocytes, under culture conditions similar to those described for PHA, the cells were centrifuged and 
Results
Basal intracellular cAMP levels in subsets of resting T cells.
As shown in Fig. 1 Forskolin (10-' M) was used to stimulate cellular adenylate cyclase maximally in order to determine the true maximal base upon which the autacoids could act. As shown in Fig. 4 , the degree of adenylate cyclase stimulation was higher with forskolin as compared to histamine or isoproterenol. This indicated that histamine or a beta adrenergic agonist, isoproterenol, could only stimulate cAMP up to a certain limit, even though more adenylate cyclase was still available. After 48 h of incubation with Con A, forskolin-induced cyclic AMP accumulation was enhanced in all subsets. But as was the case with PHA stimulation, Con A increased histamine-induced enhanced production only in TH and Tc cells. Once again the responses to histamine but not isoproterenol were augmented. The kinetics of the augmented response were specific to given subsets and generally paralleled the response conditioned by PHA. The basal cAMP levels in all subsets were unaffected by Con A.
Blocking the effect of histamine by H, and H2 antagonists.
The dramatic rise in cAMP accumulation in response to histamine in mitogen (PHA)-treated TH and Tc cells was totally (Fig. 5) and competitively blocked by cimetidine, an H2
antagonist. An H, receptor antagonist, mepyramine, did not modify the histamine-induced changes in cAMP within resting or mitogen-stimulated cells (Fig. 5) . The histamine antagonists did not block forskolin-induced cAMP accumulation (data not shown) in any subset of T cells. 
inducer cells, the Leu 2+, 9.3-subset includes most T cells capable of suppressing immunity, and the Leu 2+, 9.3+ subset includes all or nearly all (HLA, A, B) class 1 major histocompatibility complex alloantigen-specific Tc cells (10) (11) (12) . The pharmacologic response to histamine and isoproterenol was shared by most resting T cells. However, the rank order of potency of each of the two autacoids was specific to the given subset: Con A and PHA enhanced only the response to histamine and then only in selected subsets. The kinetics of the enhancement were also characteristic of a given subset. If we had performed these experiments only on unseparated T cells we would not have observed either the apparent control of T6 cells over the T, cells basal cyclic AMP or the remarkable selectivity of autacoid effects.
The selectivity of qualitative and quantitative responses to histamine and isoproterenol could be explained by a nonrandom distribution and density of receptors among subsets. In similar experiments using clones of murine T cells we found distinct categories of responses to histamine and beta agonists that were peculiar to a given clone (1 6a). Some clones responded to both histamine and isoproterenol, others to either or neither agonist. These observations may further support the nonrandom nature of the distribution of receptors for autacoids on T cell subsets. The selectivity in the responsiveness of different populations of T cells to beta adrenergic agonists and histamine had earlier been reported (17) (18) (19) . Corticosteroid resistant murine thymocytes were less responsive to isoproterenol than untreated thymocytes. The latter were more responsive than lymphoid cells from spleen, lymph node, and blood (17). Niaudet et al. (19) reported that T lymphocytes isolated from human peripheral blood produced more cAMP in response to isoproterenol than T cells isolated from human tonsils and adenoids.
An alternative explanation for the selectivity of responses could be due to differences among cells in their degree of coupling of the receptors to the adenylate cyclase pool. We have observed that different populations of T cells responded to forskolin in a selective fashion, which suggests that each subset contains a specific quantity of adenylate cyclase characteristic of that subset. In related studies we have found (16a) quantitatively additive effects of maximally effective doses of histamine and isoproterenol on cAMP accumulation in clones of mouse T, cells. These data offer an example of histamine and beta receptors that may be linked to separate and independent adenylate cyclase pools.
Activation of T cells with mitogen (PHA or Con A) did not produce a significant change in basal levels of cAMP among the subsets. These data differ from reports (20, 21) that certain immunologic stimuli such as mitogens increased concentrations of intracellular cAMP.
Interestingly, culture of T cells with mitogens conditioned the response to one autacoid, histamine, but not to the other, isoproterenol. This conditioning occurred only in selected cells, the T, and TH subsets. The conditioning of responses through the Tc and TH cells was both time and circumstance (cell mixture) dependent. Thus, the probable mechanisms of selective and organized responses to autacoids in vivo begin to emerge. After separation into Leu 3+ and Leu 2+ subsets, the response of Leu 3+ cells to histamine was augmented severalfold, whereas there was no significant change in response among the Leu 2+ subset. When Leu 2+ cells were further separated into Leu 2+, 9.3+ and Leu 2+, 9.3-subsets, the response to histamine among the Leu 2+, 9.3-subset remained unaltered, whereas the response in the Leu 2+, 9.3+ subset was increased severalfold. We In related studies (13) we have found that the Leu 2+, 9.3-subset includes all histamine-inducible suppressor cells and that after treatment with histamine these cells inhibit both PHA-induced T cell proliferation and pokeweed mitogeninduced B cell differentiation. A histamine H2 receptor antagonist (cimetidine), but not an HI receptor antagonist (mepyramine), blocked the induction of suppressor cells, which suggests that activation of Leu 2+, 9.3-cells with histamine may be mediated by H2 but not by HI receptors.
To our knowledge, regulation of histamine receptor-mediated cAMP production in cytolytic T cells by T, cells has not been previously reported. Plaut et al. (24) suggested that lymphocytes mediating cellular immunity develop receptors for histamine as a function of time after immunization. They also found an increase in the inhibitory effects on the function of cytolytic cell action correlated with the enhanced responsiveness in production of cyclic AMP. 10 d after immunization, histamine caused only -10% inhibition of cytolysis, which gradually rose to >50% by day 16. In contrast, dibutaryl cAMP, cholera enterotoxin, isoproterenol, and prostaglandin E caused consistent inhibition of cytolytic activity regardless of time elapsed after immunization. These experiments suggest that the cytolytic mechanism itself is inhibited by cyclic AMP at all times, but that histamine receptors develop gradually on killer lymphocytes only after immunization.
We know that agents that elevate intracellular cAMP also alter the immunological activity of cells (6) (7) (8) . The mechanisms by which cAMP affects the immune process are not clear. We believe that further understanding of the mechanisms by which the Leu 2+, 9.3-subset modulates the expression or function of the H2 receptor will be helpful in understanding the role of the autacoids and the second messenger in immune processes.
The differential ability of the cells to respond allows a structural and dissectible sequence of predominant actions caused by a ubiquitous hormone. Understanding that sequence seems important if we are ever to use the autacoid prospectively to modulate immunity.
